David L. Vesely

7.2k total citations
302 papers, 5.9k citations indexed

About

David L. Vesely is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David L. Vesely has authored 302 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Cardiology and Cardiovascular Medicine, 77 papers in Molecular Biology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David L. Vesely's work include Heart Failure Treatment and Management (67 papers), Pigment Synthesis and Properties (19 papers) and PI3K/AKT/mTOR signaling in cancer (18 papers). David L. Vesely is often cited by papers focused on Heart Failure Treatment and Management (67 papers), Pigment Synthesis and Properties (19 papers) and PI3K/AKT/mTOR signaling in cancer (18 papers). David L. Vesely collaborates with scholars based in United States, Czechia and Russia. David L. Vesely's co-authors include A. Kalendová, William R. Gower, Chris J. Winters, Alan L. Sallman, Jaroslav Stejskal, Petr Kalenda, Gerald S. Levey, Douglas D. Schocken, David M. Rico and John R. Dietz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

David L. Vesely

296 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Vesely United States 40 2.1k 1.6k 834 714 635 302 5.9k
Mingming Zhao China 47 815 0.4× 2.3k 1.4× 292 0.4× 633 0.9× 299 0.5× 313 7.7k
Nguan Soon Tan Singapore 62 2.0k 0.9× 5.9k 3.7× 1.1k 1.4× 516 0.7× 924 1.5× 227 13.4k
Nan Jiang China 39 1.3k 0.6× 2.8k 1.8× 418 0.5× 249 0.3× 178 0.3× 223 6.6k
Yasuo Tsutsumi Japan 50 544 0.3× 4.0k 2.5× 870 1.0× 436 0.6× 178 0.3× 470 9.5k
Tetsuya Yamada Japan 50 496 0.2× 1.9k 1.2× 395 0.5× 655 0.9× 823 1.3× 425 8.0k
Hideo Yamamoto Japan 37 873 0.4× 724 0.5× 852 1.0× 1.2k 1.6× 194 0.3× 256 5.9k
Yanfeng Wang China 44 300 0.1× 3.4k 2.1× 785 0.9× 634 0.9× 262 0.4× 294 10.6k
Francesco Moccia Italy 50 449 0.2× 2.3k 1.5× 343 0.4× 440 0.6× 109 0.2× 250 8.2k
Richard A. Knight United Kingdom 63 447 0.2× 6.6k 4.1× 3.1k 3.7× 916 1.3× 467 0.7× 201 11.9k
Jong‐Wan Park South Korea 57 269 0.1× 4.2k 2.6× 1.2k 1.5× 681 1.0× 294 0.5× 327 10.6k

Countries citing papers authored by David L. Vesely

Since Specialization
Citations

This map shows the geographic impact of David L. Vesely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Vesely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Vesely more than expected).

Fields of papers citing papers by David L. Vesely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Vesely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Vesely. The network helps show where David L. Vesely may publish in the future.

Co-authorship network of co-authors of David L. Vesely

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Vesely. A scholar is included among the top collaborators of David L. Vesely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Vesely. David L. Vesely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vesely, David L.. (2014). Family of peptides synthesized in the human body have anticancer effects.. PubMed. 34(4). 1459–66. 10 indexed citations
2.
Lenz, Anne, et al.. (2010). Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice. European Journal of Clinical Investigation. 40(3). 242–249. 3 indexed citations
3.
Vesely, David L.. (2007). Urodilatin: A better natriuretic peptide?. Current Heart Failure Reports. 4(3). 147–152. 6 indexed citations
4.
Vesely, Brian A., et al.. (2007). Four Cardiac Hormones Cause Cell Death of Melanoma Cells and Inhibit Their DNA Synthesis. The American Journal of the Medical Sciences. 334(5). 342–349. 14 indexed citations
5.
Vesely, Brian A., Abdel A. Alli, Shijie Song, et al.. (2005). Four peptide hormones’ specific decrease (up to 97%) of human prostate carcinoma cells. European Journal of Clinical Investigation. 35(11). 700–710. 42 indexed citations
6.
Mohapatra, Shyam S., Richard F. Lockey, David L. Vesely, & William R. Gower. (2004). Natriuretic peptides and genesis of asthma: An emerging paradigm?. Journal of Allergy and Clinical Immunology. 114(3). 520–526. 33 indexed citations
7.
Vesely, David L., et al.. (2004). Novel therapeutic approach for cancer using four cardiovascular hormones. European Journal of Clinical Investigation. 34(10). 674–682. 36 indexed citations
8.
Vesely, David L., et al.. (2002). Atrial Natriuretic Hormone, Vessel Dilator, Long Acting Natriuretic Hormone, and Kaliuretic Hormone Decrease Circulating Prolactin Concentrations. Hormone and Metabolic Research. 34(5). 245–249. 3 indexed citations
9.
Dietz, John R., et al.. (2001). Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure. The American Journal of Cardiology. 88(1). 23–29. 11 indexed citations
10.
Vesely, David L., Robert B. Sothern, Lawrence E. Scheving, et al.. (1996). Circadian relationships between circulating atrial natriuretic peptides and serum calcium and phosphate in healthy humans. Metabolism. 45(8). 1021–1028. 7 indexed citations
11.
Vesely, David L., et al.. (1996). Processing of Long-Acting Natriuretic Peptide and Vessel Dilator in Human Plasma and Serum. Peptides. 17(7). 1155–1162. 5 indexed citations
12.
Weston, Mark, Guillermo Cintrón, Amy T. Giordano, & David L. Vesely. (1994). Normalization of circulating atrial natriuretic peptides in cardiac transplant recipients. American Heart Journal. 127(1). 129–142. 11 indexed citations
13.
Gower, William R., et al.. (1994). Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides. 15(5). 861–867. 35 indexed citations
14.
Dietz, John R., David L. Vesely, & S. J. Nazian. (1994). POSSIBLE MECHANISMS INVOLVED IN THE NATRIURETIC RESPONSE TO ATRIAL NATRIURETIC FACTOR (ANF) AND PROANF 31–67 IN THE RAT. Clinical and Experimental Pharmacology and Physiology. 21(8). 599–606. 10 indexed citations
15.
Vesely, David L., et al.. (1990). Specific binding sites for prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126. Peptides. 11(2). 193–197. 37 indexed citations
16.
Vesely, David L., Joe K. Bissett, Marvin L. Murphy, et al.. (1989). Acute and sustained release of atrial natriuretic factor with acute myocardial infarction. American Heart Journal. 118(5). 893–900. 29 indexed citations
17.
Wyeth, Richard P., et al.. (1989). Prohormone atrial natriuretic peptides 1–30, 31–67, and 99–126 increase in proportion to right ventricular pacing rate. American Heart Journal. 117(2). 385–390. 64 indexed citations
18.
Winters, Chris J., Bonnie J. Baker, Ha Dinh, et al.. (1989). Prohormone Atrial Natriuretic Peptides 1-98 and 31-67 Increase with Exercise in Congestive Heart Failure Patients. The American Journal of the Medical Sciences. 298(6). 377–382. 21 indexed citations
19.
Vesely, David L., et al.. (1987). Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aorta. Biochemical and Biophysical Research Communications. 148(3). 1540–1548. 110 indexed citations
20.
Vesely, David L., et al.. (1977). Activation of guanylate cyclase by streptozotocin and 1-methyl-1-nitrosourea.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(1). 28–31. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingming Zhao Breakdown of academic impact, for papers by Nguan Soon Tan Breakdown of academic impact, for papers by Nan Jiang Breakdown of academic impact, for papers by Yasuo Tsutsumi Breakdown of academic impact, for papers by Tetsuya Yamada Breakdown of academic impact, for papers by Hideo Yamamoto Breakdown of academic impact, for papers by Yanfeng Wang Breakdown of academic impact, for papers by Francesco Moccia Breakdown of academic impact, for papers by Richard A. Knight Breakdown of academic impact, for papers by Jong‐Wan Park
Rankless by CCL
2026